» Articles » PMID: 7432722

Effects of Prenatal Maternal Estrogen on the Male Urogenital System

Overview
Journal Obstet Gynecol
Date 1980 Nov 1
PMID 7432722
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Effects of in utero exposure to estrogens on the testis and prostate were assessed in male perinates. Exposure to diethylstilbestrol alone or combined with other female sex hormones correlated with hypertrophy and squamous metaplasia of the prostatic utricle and ducts, and with high ratios of Leydig cells to spermatogenic cells in the testis. These changes were not correlated with maternal diabetes, other congenital abnormalities, exposure to progestogens and steroidal estrogens, or thyroid hormones. Within the affected group an interaction was found between the hormones administered and the trimester during which treatment was started. These findings suggest that exogenous female sex hormones may interfere with the action of müllerian inhibiting factor in the human male fetus. The prostatic ducts also respond to maternal estrogen treatment. Relevance to later health is unknown.

Citing Articles

Prenatal Diethylstilbestrol Exposure and Cancer Risk in Males.

Strohsnitter W, Hyer M, Bertrand K, Cheville A, Palmer J, Hatch E Cancer Epidemiol Biomarkers Prev. 2021; 30(10):1826-1833.

PMID: 34272263 PMC: 8492497. DOI: 10.1158/1055-9965.EPI-21-0234.


Developmental estrogenization: Prostate gland reprogramming leads to increased disease risk with aging.

Prins G Differentiation. 2021; 118:72-81.

PMID: 33478774 PMC: 8026668. DOI: 10.1016/j.diff.2020.12.001.


Reproductive tract biology: Of mice and men.

Cunha G, Sinclair A, Ricke W, Robboy S, Cao M, Baskin L Differentiation. 2019; 110:49-63.

PMID: 31622789 PMC: 7339118. DOI: 10.1016/j.diff.2019.07.004.


Environmental endocrine disruptors: Effects on the human male reproductive system.

Sweeney M, Hasan N, Soto A, Sonnenschein C Rev Endocr Metab Disord. 2016; 16(4):341-57.

PMID: 26847433 PMC: 4803593. DOI: 10.1007/s11154-016-9337-4.


EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals.

Gore A, Chappell V, Fenton S, Flaws J, Nadal A, Prins G Endocr Rev. 2015; 36(6):E1-E150.

PMID: 26544531 PMC: 4702494. DOI: 10.1210/er.2015-1010.